Bronkiektasier
Senast uppdaterad: Publicerad:
Sakkunnig:Lennart Hansson- Nicotra MB, Riveera M, Dale AM, et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995;108:955-61. PubMed
- Clinical Evidence freelance writers. Bronchiectasis. Clin Evid 2003; 9: 1641-4. PubMed
- Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147: 6-15. PubMed
- ten Hacken NHT, Wijkstra PJ, Kerstjens HAM. Treatment of bronchiectasis in adults. BMJ 2007; 335: 1089-93. PubMed
- Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162: 1277-84. PubMed
- Mysliwiec V, Pina JS. Bronchiectasis: the ‘other' obstructive lung disease. Postgrad Med 1999;106:123-31. PubMed
- Bronchiectasis and other bronchial abnormalities. In Fraser RS, Müller NL, Colman N, Paré PD, eds. Diagnosis of Diseases of the Chest, pp 2265-97. Philadelphia: W.B. Saunders Company, 1999.
- Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis (Cochrane Review).In: The Cochrane Library, issue 1, 2001. Oxford: Update Software. The Cochrane Library
- Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev, issue 1, 2002. The Cochrane Library
- Franco F, Sheikh A, Greenstone M. Short acting beta-2 agonists for bronchiectasis. Cochrane Database Syst Rev, issue 3, 2003. The Cochrane Library
- Sheikh A, Nolan D, Greenstone M. Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst Rev, issue 4, 2001. The Cochrane Library
- Lasserson T, Holt K, Evans D, Greenstone M. Anticholinergic therapy for bronchiectasis. Cochrane Database Syst Rev, issue 4, 2001. The Cochrane Library
- Steele K, Greenstone M, Lasserson JA. Oral methyl-xanthines for bronchiectasis. Cochrane Database Syst Rev, issue 1, 2001. The Cochrane Library
- Kolbe J, Wells A, Ram FSF. Inhaled steroids for bronchiectasis (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software. The Cochrane Library
- Tsang KW, Tan KC, Ho PL, Ooi GC, Ho JC, Mak J, et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005; 60: 239-43. PubMed
- Lasserson T, Holt K, Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst Rev, issue 4, 2001. The Cochrane Library
- Corless JA, Warburton CJ. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst Rev, issue 4, 2000. The Cochrane Library
- Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst Rev, issue 2, 2000. The Cochrane Library
- Jones A, Rowe BH. Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review. Heart Lung 2000; 29: 125-35. PubMed
- Corless JA, Warburton CJ. Surgery vs non-surgical treatment for bronchiectasis. Cochrane Database Syst Rev, issue 4, 2000. The Cochrane Library
- Dogan R, Alp M, Kaya S, Ayrancioglu K, Tastepe I, Unlu M, et al. Surgical treatment of bronchiectasis: a collective review of 487 cases. Thorac Cardiovasc Surg 1989; 37: 183-6. PubMed
- Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst Rev, issue 4, 2003. The Cochrane Library
- Cymbala AA, Edmonds LC, Bauer MA, Jederlinic PJ, May JJ, Victory JM, et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 2005; 4: 117-22. PubMed
- Lin HC, Cheng HF, Wang CH, Liu CY, Yu CT, Kuo HP. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am J Respir Crit Care Med 1997; 155: 2024-9. PubMed
- Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000; 162: 481-5. PubMed
- Orriols R, Roig J, Ferrer J, Sampol G, Rosell A, Ferrer A, et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 1999; 93: 476-80. PubMed
- Keistinen T, Saynajakangas O, Tuuponen T, et al. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 1997;10:2784-7. PubMed
- Lennart Hansson, med dr och överläkare, Lung- och allergikliniken, Skånes universitetssjukhus
Tidigare sakkunniga
- Hasse Melbye, specialist i allmänmedicin, försteamanuens vid Institutt for samfunnsmedisin, Universitetet i Tromsø
- Leif Bjermer, professor i lungsjukdomar, Norges teknisk-naturvitenskapelige universitet, Trondheim